Cancer Studies and Molecular Medicine

Open journal

ISSN 2377-1518

National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Medicine, Perspective, Precision drugs, Precision medicine

2023 Feb

Karel Petrak*
National Consensus for Screening, Diagnosis and Management of Hepatocellular Carcinoma in Panama, 2022

Consensus, Guidelines, Hepatocellular carcinoma, Panama, Systematic Review

2022 Nov

Moises Cukier*, José M. Cabada-Lee, Jorge D. Méndez-Ríos, Rafaél Arauz, Erik Arauz, Norberto Carreño, Ivette Clavel, Jan A. Cubilla-Rodríguez, Dafnia De Gracia, Iván Díaz, Olivia El Achtar, Kenia Franco, Julissa Lobardo-Quezada, Yong Loo, Melisa I. Menéndez, Gaspar Pérez-Jiménez, José Pinto-Llerena, Lizka Richards-Cantoral, Mauricio Rodríguez-Bravo, Maylin Ruiz, Karen E. Suñé, Ignacio Veliz and Ruth Vergara-Vásquez

Antitumor agents, cancer, Chemotherapy, Drug development, Neoplasms, Opinion

2022 Oct

Daniel Gandia* and Cecilia Suarez
Anastasis: Cell Survival Mechanism

Anastasis, cancer, Programmed cell death, review

2020 Sep

Abolaji S. Olagunju*, Folashade G. Olorunfemi, John O. Teibo and Abiodun M. Adewolu

cancer, Cancer Dynamics, Immunotherapy, Oncogenes, Opinion, Therapeutics, Tumor suppressor genes

2020 May

Daniel Gandia* and Cecilia Suárez

cancer, Editorial, NF1, NF1 Plasma Membrane, Pathology

2020 Mar

Vincent M. Riccardi*

cancer, Chemotherapy, Heterogeneity, Opinion, Phenotype, Resistance

2019 Oct

Daniel Gandia*
Oligo-Metastatic Carcinoma Cervix: A Few Do Extremely Well

Carcinoma, Case Series, Cervix, Chemotherapy, Oligometastasis

2019 Aug

Pallavi Nair and Francis V. James*

Anticancer, Natural product;, review, Venom

2019 Aug

Ranwa A. Elrayess and Heba N. Gad El-Hak*
Deep-Ultraviolet Raman Spectroscopy for Cancer Diagnostics: A Feasibility Study with Cell Lines and Tissues

Cancer diagnostics, Deep-ultraviolet resonance Raman spectroscopy, Original Research, Prostate Cancer

2019 Apr

Nicole M. Ralbovsky, Vladimir Egorov, Eugene Moskovets, Paromita Dey, Bijan K. Dey and Igor K. Lednev*

African American Community, Breast cancer, Editorial

2019 Apr

Jennifer Sims-Mourtada*, Zohra Ali-Khan Catts, Patricia Swanson and Nora Katurakes
The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy

Early life exposure, Environmental factors, Systematic Review, Uterine fibroids

2018 Sep

Qiwei Yang*, Mohamed Ali, Abdeljabar El Andaloussi, Ayman Al-Hendy
A Case of Choroidal Metastasis from Small-Cell Lung Carcinoma

Choroidal metastasis, Illustration, Ocular metastasis, Small-cell lung carcinoma, Thoracic computed tomography, Visual disturbance

2018 Jul

Manami Inoue, Takeshi Saraya*, Miku Oda, Masachika Fujiwara and Hajime Takizawa
Bilateral Symmetric Thalamic Metastasis in a Patient with Small Cell Lung Cancer

Brain metastasis, Chemotherapy, Illustration, Small cell lung cancer, Symmetric numbness, Thalamic metastasis

2018 Jul

Takeshi Saraya*, Chie Shimura, Sayuki Inaoka and Hajime Takizawa

cancer, Editorial, Mutations, p27

2018 May

Qiwei Yang* and Ayman Al-Hendy

Case Report, Mucinous, Urachal remnant

2018 Feb

Kanchan K. Palial*, Bob Yang, Philip J. S. Charlesworth, Charles E. Lewis, Lisa Browning and Clare Verrill
Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy

Case Study, Dosimetric, Radiation, Stereotactic body radiotherapy (SBRT)

2018 Jan

Jennifer Sims-Mourtada*, Serguei Casteneda, David Huang, John McGlade, Sunjay Shah, Lindsay Romak, Adam Raben and Firas Mourtada
Classifying Lung Adenocarcinoma and Squamous Cell Carcinoma using RNA-Seq Data

LASSO, LUAD, LUSC, Original Research, Principal Components

2017 Sep

Zhengyan Huang, Li Chen and Chi Wang*

cancer, Dysadherin, Editorial, Oesophageal Cancer

2017 Jul

Alexandros Charalabopoulos* and Theodoros Liakakos

Biomarkers, Disease detection, Energy metabolism, Letter to the Editor, Metabolic syndrome, Mitochondrial DNA

2017 May

Vasudeva G. Kamath*

Editorial, Molecular Imaging, Molecular Medicine

2017 Jan

Pradeep K. Garg*
Rounding Down Chemotherapeutic Agents to the Nearest Vial Size as a Cost Containment Measure

Chemotherapy wastage, Cost-saving, Dose rounding, Original Research

2016 Oct

Yousef Al-Olah, Nasser Mahdi Al-Qhtani*, Maj Mohammed A. Al Waheeby, Abdul-Rahman I. Al-Ghamdi, Ghadah Al Yousif, Al Hanouf N. Al Dajani, Nourah M. Al Henaki and Ahlam M. Al Zahrani
Prostate Cancer Trends in Developing Countries

cancer, Cancer Trends, Developing Countries, Editorial, Prostate Cancer, Prostate Cancer Trends

2016 Sep

Aleyamma Mathew and Francis V. James*
Gastrointestinal Stromal Tumors: Innovation from Diagnosis

Gastrointestinal Stromal Tumors (GIST), Innovation, Observational Study, Target therapies

2016 Apr

Joana Espiga de Macedo*, Sílvia Lopes, Mónica Pinho and Pedro Santos

Epidermal growth factor receptor (EGFR), Head and neck-targeted therapy, Original Research

2016 Mar

Cessal Thommachan Kainickal*, Aparna M. P., Rejnish Kumar Ravi Kumar, Malu Rafi and Kunnambath Ramadas
The Proportion of ALDEFLUOR-Positive Cancer Stem Cells

ALDEFLUOR, Cancer stem cells, Density, Original Research

2015 Dec

Lynn M. Opdenaker, Shirin R. Modarai and Bruce M. Boman*

Mini Review, Radiotherapy, Treatment, Tumors

2015 Nov

Milan Anjanappa, Cessal Thommachan Kainickal and Francis V. James*

Boosting Response, Editorial, Immunotherapy, Impact of Immune Checkpoint Inhibitors, Radiation Treatment

2015 Sep

Firas Mourtada and Jennifer Sims-Mourtada*
Skin Hypopigmentation in a Patient with Papillary Carcinoma

Case Report, Hypopigmentation, Sorafenib, Thyroid Carcinoma

2015 Aug

Athira Raju, Mathews Jose, Arun Philip and Keechilat Pavithran*

Gastrointestinal Stromal Tumors (GISTs), Imatinib, Molecular Signaling Pathways, Opinion, Treatment, Tumor Heterogeneity

2015 Aug

Joana Espiga de Macedo*

cancer, Checkpoint inhibitors, Cytokines, Immuno-oncology, Immunotherapy, Impact of Immune Checkpoint Inhibitors, Letter to the Editor

2015 Jul

Anoop Kumar*
Long Term Low Dose Genistein decreases Stem Cell Populations

Genistein, Inflammatory breast cancer, Short Communication

2015 Mar

Jennifer Sims-Mourtada*, Lynn M. Opdenaker, Joshua Davis and Changqing Wu
MAPK/ERK Activation Sensitizes MKN-28 Cells to Cisplatin

Apoptosis, Cisplatin, Gastric cancer, Original Research

2015 Mar

Zhan-Guo Zhang, Yan-Hui Wu, Hui-Fang Liang, Bi-Xiang Zhang and Wan-Guang Zhang*

cancer, Flavones, Flavonols, review, Xenografts

2015 Mar

Mark F. McCarty*
Elimination of Tumor Suppressor Proteins during Liver Carcinogenesis

Gankyrin, Liver cancer, review, Tumor suppressor genes

2014 Dec

Nikolai A. Timchenko* and Kyle Lewis
Effects of Three Dimensional Microenvironment on Tumorigenicity of Fibrosarcoma in vitro

Fibrosarcoma, Microenvironment, Original Research

2014 Nov

Irit Levinger, Racheli Zagouri, Yvonne Ventura and Razi Vago*
Role of Molecular Imaging in Oncology

Antibody, Editorial, Imaging, Tumor

2014 Jul

Pradeep K. Garg*, Surinder K. Batra and Sudha Garg
Application of Radionuclides and Antibody -Drug Conjugates to Target Cancer

Monoclonal antibody, Radionuclide therapy, review, Targeted alpha therapy

2014 Apr

Sean L. Kitson*
Regulation in Cell Cycle via p53 and PTEN Tumor Suppressors

AKT, Mini Review, p53, Protein degradation, PTEN

2014 Apr

Yasuko Kitagishi*, Satoru Matsuda*, Akari Minami, Yuna Ono, Atsuko Nakanishi and Yasunori Ogura

Special Editions

About the Journal

Cancer is defined as the uncontrolled growth or division of cells that results in benign (stationary tumours) or malignant (invading/spreading to nearby parts of the body) tumours.

Cancer, which is the most researched topic in the scientific world due to its unstable treatment methods, is one of the leading causes of death today.

Molecular medicine, on the other hand, is a broad field that incorporates physical, chemical, biological, and medical techniques to depict various molecular structures and their mechanisms. This topic has demonstrated its significance in the field of cancer by amplifying molecular-level dysfunctionalities during the cell cycle.

Therefore, advanced diagnostic techniques for cancer management and treatment have been developed to analyse and monitor the root cause of molecular-level malfunction.
As result, scientists were able to identify and comprehend the factors that contribute to tumour development at the cell cycle level, and they were able to devise and implement controlled measures to prevent cancer.
However, Openventio’s open journal aims to disseminate detailed information about cancer research, prevention and treatment to the scientific community for its benefit.


Pradeep Garg is an Editor-in-Chief of Cancer Studies and Molecular Medicine – Open Journal at Openventio Publishers.

Pradeep Garg, PhD

Center for Molecular Imaging and Therapy (CMIT) — Shreveport

Associate editors

JENNIFER SIMS-MOURTADA is an Associate Editor of Cancer Studies and Molecular Medicine – Open Journal at Openventio Publishers.

Jennifer Sims-Mourtada, PhD

Center for Translational Cancer Research, Helen F. Graham Cancer Center


Somayeh Vafaei, PhD

Department of Obstetrics & Gynecology, University of Chicago


Unnati M. Pandya, PhD

Discovery Biology, Exo Therapeutics, Inc.


Masahiko Tanabe, MD, PhD

Department of Breast and Endocrine Surgery, The University of Tokyo Hospital


Francis V. James, MD

Department of Radiation Oncology, Regional Cancer Centre


Keechilat Pavithran, DM, MD

Department of Medical Oncology and Hematology, Amrita Vishwa Vidyapeetham


Jian Pan, PhD

Department of Hematology and Oncology, Childrens Hospital of Soochow University


Sajeed A. Rahuman, DM(RT), MD(RT)

Department of Radiation Oncology, Regional Cancer Centre


Khalid Al-Nedawi, PhD

Department of Medical Sciences, McMaster University


Ramachandran Murali, PhD

Department of Biomedical Sciences, Cedars-Sinai Medical Center


Li Chen, PhD

Department of Biostatistics, University of Kentucky


Daniel D. Taub, PhD

Washington DC VA Medical Center


Alexandros Charalabopoulos, MD, PhD

National & Kapodistrian University of Athens


Gokul Das, PhD

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute


Shreya Kanodia, PhD

Department of Biomedical Sciences, MD Anderson Cancer Center


Young K. Chae, MD, MPH, MBA

Feinberg School of Medicine, Northwestern University


Sun-Young Kong, MD, PhD

Department of Cancer Biomedical Science, National Cancer Center Korea


Saeed Sadeghi, MD

UCLA Santa Monica Hematology-Oncology Community Practice Group


Chatchawin Assanasen, MD

Division of Hematology-Oncology, UT Health San Antonio


Myriam N. Bouchlaka, PhD

Immuno-Oncology/Pharmacology at OncoResponse Inc.


Frank S. Lieberman, MD

Department of Neurology, University of Pittsburgh School of Medicine


Walter A. Hall, MD, MBA

Norton College of Medicine, SUNY Upstate Medical University



Necy S. Juat, MD

National Kidney and Transplant Institute, Philippines

Namrata Jayanth, PhD

Bristol Myres Squibb Research Centre, India

Astha Malik, PhD

Cincinnati Children’s Hospital Medical Center, USA

Poorva Sandlesh, PhD

University of Pennsylvania, USA

Jeanette Reece, PhD, MPH

University of Melbourne, Australia

Asha Eapen, PhD

University of Illinois, USA

Pavan Rajanahalli, PhD

University of Tampa, USA

Oorvashi R. Puli, PhD

University of Dayton, Australia

Shubha Ghosh, PhD

University of California Los Angeles, USA

Yan P. Yu, MD, PhD

University of Pittsburgh, USA

Zhong Liu, PhD

NovaRock Biotherapeutics Ltd, USA

Karel Petrak, MSc, DPhil

NangioTx, Inc, USA


University of Texas, USA

Jennifer L. Bishop, PhD

The University of British Columbia, Canada

James J. Yu, PhD

Harvard Medical School, USA

Supriya Sen, PhD

University of California Los Angeles, USA

Tao Wang, PhD

UT Southwestern Medical Center, USA

Tsai Ming-Ming, PhD

Chang-Gung University of Science and Technology, Taiwan

Feedback Corner

Karel Petrak, DPhil is an author at Openventio Publishers

NangioTx Inc., — CSMMOJ


The process of publishing my manuscript by Cancer Studies and Molecular Medicine — Open Journal went smoothly, as promised. My manuscript was accepted for publication following a peer review. Subsequently, I was guided in reviewing the galley proof, providing corrections, and finalizing the manuscript. The manuscript was published without any delay.

Abolaji S. Olagunju, MSc is an author at Openventio Publishers

University of Ibadan - CSMMOJ


Writing a manuscript is one thing, getting a good publisher/Journal is another thing entirely. I appreciate Cancer Studies and Molecular Medicine for finding my article worthy of publishing. Perfect review process and good communication with authors.

Vincent M. Riccardi, MD, MBA is an author at Openventio Publishers

The Neurofibromatosis Institute - CSMMOJ


NF1 is an important disease, respecting the huge numbers of patients and the insights that the disorder and the gene have for other human situations. This disorder has been my focus for 48 years. I was pleased to share such thoughts through Cancer Studies & Molecular Medicine – Open Journal.

Daniel Gandia, MD is an author at Openventio Publishers

Clinical Oncologist - CSMMOJ


Cancer Studies and Molecular Medicine – Open Journal is an eye-opener to publish with. The reviewers are highly qualified and their comments were accepted by me in order to organize a better structure and add something more in the paper. Happy to have my first paper in this journal.

Alexandros Charalabopoulos, MD, PhD is an author at Openventio Publishers

Broomfield Hospital – CSMMOJ


Having published my research with Openventio I can without any doubt state that their professionalism is of a high standard as their Journals continuously try to make the academic world better with benefit to both researchers and patients.

connect with us

Indexed in